Commission Delegated Regulation (EU) 2019/397 provides for an amendment to Commission Delegated Regulation (EU) 2016/2251 as regards the date until which counterparties may continue to apply their risk-management procedures for certain OTC derivative contracts not cleared by a CCP. Pursuant to Article 2 of Delegated Regulation (EU) 2019/397, that Regulation is to apply from the date following that on which the Treaties cease to apply to and in the United Kingdom pursuant to Article 50(3) of the Treaty on European Union, unless a withdrawal has entered into force by that date or the two-year period referred to in Article 50(3) of the Treaty on European Union has been extended.
Recital 2, Commission Delegated Regulation (EU) 2019/564 of 28 March 2019 amending Delegated Regula…
In forcesince 28 Mar 2019